跳至主要内容
临床试验/KCT0003701
KCT0003701招募中未知

arrowband ultraviolet B phototherapy for patients with uremic pruritus

Kangdong Sacred Heart Hospital0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 90(Year)(—)
性别
All

入选标准

  • 1. Patients with end-stage renal failure or with an eGFR of less than 60.
  • 2. Patients who signed the written consent with explanation of the purpose, method and effect of the clinical trial
  • 3. Within 1 year from the date of the study agreement, patients who had received the following ? or ? treatment for pruritus but did not improve symptoms
  • ? the antihistamine or anti-allergic drugs which are specialized medicines with indication of pruritus, two or more consecutive weeks of systemic therapy
  • ? ointment or topical therapy which are specialized medicines with indication of pruritus

排除标准

  • 1. Patients with a history of renal transplantation
  • 2. Patients with systemic infection
  • 3. Patients who are pregnant

研究者

相似试验

尚未招募
不适用
Efficacy of narrowband ultraviolet B phototherapy for patients with intractable pruritus cutaneus
JPRN-UMIN000038976agoya City University30
进行中(未招募)
不适用
arrow band UV-B phototherapy and fluticasone proprionate versus narrow band UV-B phototherapy and placebo for the treatment of active vitiligo: a randomized double blind controlled trial - UVBVITarrow band ultra violet B phototherapy is the gold standard for the treatment of vitiligo vulgaris. Ultra violet A and fluticasone proprionate (cutivate) together have shown significant better repigmentation than both treatments alone in a study by Westerhof et al in 1999. We expect that the combination of narrow band ultra violet B and fluticasone proprionate will have a significantly better result in terms of repigmentation for the treatment of vitiligo.
EUCTR2008-006903-22-NLAcademic Medical Center
招募中
1 期
Targeted broadband UV-B phototherapy in pityriasis alba
CTRI/2017/12/010882IADV50
招募中
1 期
The use of ultraviolet light photochemotherapy Polarised Ultra Violet A [PUVA] in the oral cavity in conjunction with a oral photo-sensitiser [5-methoxypsolaren or 8-methoxypsoralen] for oral graft-versus- host disease [GVHD] in allogeneic bone marrow transplant patients [ABMT].Chronic Oral Graft versus Host DiseaseBlood - Haematological diseases
ACTRN12613000330741St Vincent's Hospital, Sydney25
已完成
2 期
Effect of narrow band UVB phototherapy plus betamethasone ointment versus narrow band UVB phototherapy plus placebo ointment on the treatment of vitiligoVitiligo.Vitiligo
IRCT201402269014N26Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences30
arrowband ultraviolet B phototherapy for patients... | 临床试验